News
Hengrui weighs Hong Kong IPO to drive the next phase of global expansion
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.
36Kr is China's most influential business and technology network. Since 2010, 36Kr has been delivering high-quality content focused on China’s innovation and new economy trends. With its extensive traffic and network, 36Kr has built a comprehensive database and strong data analytics capabilities to provide insights into China’s technology landscape.
News
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.